As per Future Market Insights, the next-generation biomanufacturing market is anticipated to attain a value pool of USD 20 billion by 2023-end. Global adoption for next-generation biomanufacturing is expected to rise at a CAGR of 7.2% to USD 40 billion in 2033.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value of Next-Generation Biomanufacturing in 2023 | USD 20 billion |
| Projected Market Value of Next-Generation Biomanufacturing in 2033 | USD 40 billion |
| Growth Rate (2023 to 2033) | 7.2% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Principal Consultant
Overall, the application of AI in biomanufacturing is a rapidly evolving field with enormous potential to transform the industry. As AI technologies continue to advance, we can expect to see even greater efficiency, cost savings, and improved product quality in the biomanufacturing market.
The sudden progression of the biopharmaceutical industries represents the rising importance of the biomanufacturing as the chief procedure for the evolution and manufacture of the biological-based products, this is called the next-generation biomanufacturing market.
Next-generation biomanufacturing products are developed to provide consistent services that is better as compared to the first generation biomanufacturing products both in terms of quality and efficiency. Next-generation biomanufacturing market is focusing towards the use of single-use products such as single-use bio-containers and single-use bio-reactors, this is the most popular trends in the next generation biomanufacturing market.
This has led to the large numbers of advantages in the next-generation biomanufacturing market such as the reduced risk of contamination of products, adoption of cost savings facilities. The outbreak of novel coronavirus is believed to have an enduring impact on biopharmaceutical manufacturing.
Due to the COVID-19 pandemic, development of vaccines has become the main goal of the biomanufacturing industries. The development of advanced vaccines will also influence the growth of the biopharmaceutical industry post coronavirus pandemic.
Scientists and engineers are now focusing to develop the next-generation biomanufacturing functioning that can produce advanced vaccines in a cost-effective manner. They are also focusing on the quantities of the vaccines which would be needed to respond to future outbreaks and pandemic.
Rising number of biopharmaceutical companies across the world is expected to drive the next generation bio-manufacturing market in the forecast period. The need for advanced biomanufacturing to fulfil the demand of the patients is expected to boost up the growth of the next-generation biomanufacturing market.
Increasing investment of government and private organizations on the development of the innovative technology is expected to further boost various opportunities which in turn will lead to the growth of next-generation biomanufacturing market.
Many companies innovating products to enter into the next-generation biomanufacturing market, various novel next-generation biomanufacturing products are expected to be launched which would drive the growth of the next-generation biomanufacturing market.
Increasing awareness among the people regarding the benefits of the next-generation bio-manufacturing market would lead to the growth of the market. Based on the type, upstream biomanufacturing is expected to be the preferred process in the global next-generation biomanufacturing market.
Based on the application, the monoclonal antibody product segment is expected to dominate the next-generation due to high rate of products approval. Monoclonal antibodies to be followed by vaccines due to the current outbreak of novel coronavirus.
Based on end-user, biopharmaceutical companies are expected to be the major contributor of the revenue in the next-generation biomanufacturing market. North America is expected to dominate the next-generation biomanufacturing market due to the higher adoption of advanced technology and the prevalence of manufacturing industries in the region.
North America is expected to be followed by Europe. Asia-Pacific is expected to be the fastest-growing next-generation biomanufacturing market due to the rising population in countries like India and China. Latin America market is expected to experience the constant growth rate in the next-generation bio-manufacturing market whereas the Middle East & Africa expected to be the least profitable market due to lower adoption of advanced technology.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global next-generation bio-manufacturing market has been segmented based on workflow type, application and end-user.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Workflow Type 6.2. Application 6.3. End-User 7. Global Market Analysis and Forecast, By Workflow Type 7.1. Upstream Biomanufacturing Workflow 7.2. Single-Use Upstream Biomanufacturing Workflow 7.3. Downstream Biomanufacturing Workflow 8. Global Market Analysis and Forecast, By Application 8.1. Monoclonal Antibodies 8.2. Vaccines 8.3. Recombinant protein 8.4. Hormones 8.5. Others 9. Global Market Analysis and Forecast, By End-User 9.1. Biopharmaceutical Companies 9.2. Research Institutions 9.3. Contract Research Organizations 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. Asia Pacific 10.5. Middle East & Africa 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 16. Sales Forecast by Workflow Type, Application, and End-User for 30 Countries 17. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 18. Company Profile 18.1. Sartorius AG 18.2. Merck & Co. 18.3. Meissner Filtration 18.4. ESCO Group LLC 18.5. Solaris Biotechnology 18.6. Applikon Biotechnology 18.7. GEA Group AG 18.8. PBS Biotech Inc. 18.9. bbi-biotech GmbH 18.10. Danaher Corporation 18.11. bbi-biotech GmbH
Explore Healthcare Insights
View Reports
Next-Generation Biomanufacturing Market
